A Deep Dive into the Struggles Behind Hydroponics and the Future of SMG
The Rise and Fall of Scotts’ Hydroponics Bet
The Scotts Miracle-Gro Company (SMG) has long been a household name in the lawn and garden industry. With a strong presence in the consumer market, it seemed only natural for the company to expand into the booming world of hydroponics and vertical farming. This vision took shape in 2015 with the launch of Hawthorne Gardening Company, a subsidiary designed to serve the emerging cannabis cultivation industry. The timing seemed ideal as states like Colorado were leading the charge in cannabis legalization.
However, the reality of the market did not match expectations. Hopes for widespread federal legalization stalled, and the cannabis industry quickly became saturated. With increased competition and a market that failed to scale as predicted, the growth of Hawthorne stagnated. What was once seen as a promising future pivot became a volatile liability on the company’s balance sheet.
Strategic Pivot: Breaking Away from Cannabis
Facing mounting pressure from investors and underwhelming returns from the hydroponics segment, Scotts Miracle-Gro announced plans to spin off Hawthorne. This move was part of a broader strategy to remove the instability associated with cannabis and focus on the company’s core strengths in lawn and garden care. CEO James Hagedorn emphasized that separating Hawthorne could potentially unlock higher valuation multiples for the remaining business and bring more clarity to the company's growth narrative.
This decision signaled a significant shift in the company’s long-term vision. By narrowing its focus and shedding the more experimental branch of its operations, Scotts aimed to realign with investor expectations and return to profitability.
Financials Reveal a Clear Divide
For the fiscal year ending September 2024, Scotts Miracle-Gro reported net sales of approximately $3.6 billion, consistent with the previous year. The U.S. Consumer segment showed resilience, growing 6% year-over-year and reaching $3.0 billion in sales. This growth was largely driven by expanded shelf space and strong retail partnerships.
In stark contrast, the Hawthorne segment saw sales plummet by 37%, ending the fiscal year at just under $295 million. The decline was primarily linked to the discontinuation of its third-party distribution arm, further signaling the company’s retreat from its hydroponic ambitions.
Despite these mixed results, the overall gross margin showed signs of improvement, with a GAAP margin of 23.9% and a non-GAAP adjusted margin of 26.3%, suggesting that streamlining operations may be helping the company regain its footing.
SMG Stock Performance: A Tough Road Ahead
As of early April 2025, SMG shares were trading at $48.21, down over 8% from the previous session. The stock has struggled to maintain momentum, reflecting broader concerns about the company’s direction and the declining relevance of its hydroponics business.
The intraday trading range has been wide, further indicating market uncertainty. While some investors see potential in Scotts’ return to its core roots, others remain skeptical about whether the company can truly rebound without a strong growth catalyst.
Is SMG Still Worth Your Investment?
Scotts Miracle-Gro is far from a failed company. Its legacy in consumer gardening remains intact, and the recent strategic shift away from hydroponics could very well help the business stabilize. But when it comes to vertical farming and hydroponics, SMG is no longer a compelling play. Investors looking for exposure to these emerging sectors may want to look elsewhere—toward firms that are fully committed to innovation in indoor agriculture and better positioned to navigate the regulatory landscape.
For now, SMG appears to be retreating from the future it once sought to lead. Whether that’s a prudent correction or a missed opportunity depends entirely on your investment strategy.